Moderna (NASDAQ: MRNA) reported Q4 EPS of $11.29, $1.39 better than the analyst estimate of $9.90. Revenue for the quarter came in at $7.2 billion versus the consensus estimate of $6.78 billion.

• Moderna announces a new $3 billion share repurchase plan

For earnings history and earnings-related data on Moderna (MRNA) click here.